CMS expanded coverage of mitral valve transcatheter edge-to-edge repair procedures, previously known as transcatheter mitral valve repair, to include patients with symptomatic moderate-to-severe or severe mitral functional regurgitation, also called secondary MR. The move significantly grows the U.S. patient pool eligible for coverage.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,